Hanan Costeff
Hanan Costeff was an Israeli physician and geneticist known for his contributions to the field of medical genetics. He is particularly recognized for his work in identifying and characterizing genetic disorders, including the discovery of Costeff syndrome, a rare inherited disorder.
Early Life and Education[edit | edit source]
Hanan Costeff was born in Israel. He pursued his medical education at the Hebrew University of Jerusalem, where he earned his medical degree. Following his graduation, Costeff specialized in pediatrics and later in medical genetics.
Career[edit | edit source]
Costeff's career was marked by his dedication to the study of genetic disorders. He worked at several prestigious institutions, including the Hadassah Medical Center in Jerusalem. His research primarily focused on the identification and characterization of rare genetic diseases.
Costeff Syndrome[edit | edit source]
One of Costeff's most significant contributions to medical genetics was the identification of Costeff syndrome, also known as 3-methylglutaconic aciduria type III. This disorder is characterized by optic atrophy, movement abnormalities, and intellectual disability. Costeff's work in identifying the syndrome has been crucial in understanding its genetic basis and in providing a diagnosis for affected individuals.
Research and Publications[edit | edit source]
Throughout his career, Costeff published numerous articles in scientific journals, contributing valuable knowledge to the field of medical genetics. His research has been widely cited and has had a lasting impact on the study of genetic disorders.
Legacy[edit | edit source]
Hanan Costeff's work has left a lasting legacy in the field of medical genetics. His contributions have helped in the diagnosis and understanding of rare genetic disorders, providing a foundation for future research and treatment.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD